Xencor (XNCR) EPS (Diluted) Growth (3y) (2016 - 2026)
Xencor (XNCR) EPS (Diluted) Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 78.99% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 37.28% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.39% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -2.00% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 83.94% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Xencor | 1.47 Bn | 1.09 Bn | - | -20.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.48% |
| Dec 31, 2025 | 23.72% |
| Sep 30, 2025 | 47.15% |
| Jun 30, 2025 | 10.06% |
| Mar 31, 2025 | -54.81% |
| Dec 31, 2024 | -37.30% |
| Sep 30, 2024 | -2.47% |
| Jun 30, 2024 | -48.70% |
| Mar 31, 2024 | -204.51% |
| Dec 31, 2023 | -22.03% |
| Sep 30, 2023 | -22.24% |
| Jun 30, 2023 | -24.66% |
| Mar 31, 2023 | -90.48% |
| Dec 31, 2022 | 24.02% |
| Sep 30, 2022 | -44.85% |
| Jun 30, 2022 | -26.12% |
| Mar 31, 2022 | -34.58% |
| Dec 31, 2021 | 77.37% |
| Sep 30, 2021 | -145.25% |
| Jun 30, 2021 | 56.92% |